On Tuesday, beleaguered electronics retailer Best Buy (NYSE: BBY ) announced that it had reached an agreement to sell its 50% stake in Best Buy Europe for approximately $775 million. Best Buy Europe was a joint venture with Carphone Warehouse that previously operated a handful of Best Buy big-box stores, and has continued to operate Carphone Warehouse's retail operations. Best Buy investors cheered the news, sending the company's stock up by as much as 11%, to a new 52-week high.
Investors' enthusiasm for the deal is very easy to understand. The sovereign debt crises in Europe have led to sluggish growth at best -- and recession in many cases -- across the continent. This economic weakness, along with growing competition from e-commerce leaders like Amazon.com, led to the rapid demise of the Best Buy big-box stores in Europe. Even the more established Carphone Warehouse small stores have struggled; in Tuesday's announcement, Best Buy stated that they were not expected to produce a material profit this year. However, while this decision is a clear positive for Best Buy, the company's stock still seems overvalued in light of the challenges Best Buy faces.
5 Best Airline Stocks To Own For 2015: Argos Therapeutics Inc (ARGS)
Argos Therapeutics, Inc (Argos), incorporated on May 8, 1997, is a development stage biopharmaceutical company. The Company is focused on the development and commercialization of personalized immunotherapies for the treatment of cancer and infectious diseases based on its technology platform called Arcelis. The Company�� advanced product candidate is AGS-003 for the treatment of metastatic renal cell carcinoma, (mRCC). As of December 31, 2010, the Company was developing a second Arcelis-based product candidate, AGS-004 for the treatment of human immunodeficiency virus (HIV), and two other product candidates: AGS-009, a monoclonal antibody for the treatment of lupus, and AGS-010, a preclinical biologic compound for the treatment of psoriasis and for organ transplantation.
The Company uses its Arcelis platform to generate Ribonucleic Acid (RNA) loaded dendritic cell immunotherapies using biological components derived from the individual patient to be treated. It manufactures these personalized therapies using that patient�� disease sample, either tumor cells in the case of cancer or a blood sample containing virus in the case of infectious disease, and dendritic cells derived from the patient�� white blood cells. The Company�� AGS-003 is tested in clinical trials in combination with sunitinib and as a monotherapy for the treatment of mRCC.
Advisors' Opinion:- [By gurujx]
Argos Therapeutics Inc (ARGS) Reached the 3-year Low of $6.52
The prices of Argos Therapeutics Inc (ARGS) shares have declined to close to the 3-year low of $6.52, which is 54.8% off the 3-year high of $13.74.
- [By John Udovich]
Last week had been a busy week for biotech IPOs and follow-on offerings plus news from small cap biotech stocks like Omeros Corporation (NASDAQ: OMER), Argos Therapeutics Inc (NASDAQ: ARGS), Revance Therapeutics Inc (NASDAQ: RVNC) and TNI BioTech (OTCMKTS: TNIB) that�� worth noting as a new trading week begins:�
Top 10 Gas Utility Companies To Own For 2014: Canada Bread Company Ltd (CBY)
Canada Bread Company, Limited is a manufacturer and marketer of flour-based products in its various markets, including fresh bread in Canada, frozen partially baked bread in the United States and Canada, specialty bakery products, including fresh pasta and sauces, sweet goods and snack cakes in Canada, and bagels, croissants and other specialty baked goods in the United Kingdom. It operates in two segments: Fresh Bakery business includes pantry breads, rolls, flatbreads, artisan breads, sweet goods and snack cakes sold under a number of brands, including Dempster��, Villaggio, POM, Bon Matin and Ben��, and Frozen Bakery segment consists of frozen par-baked bakery products sold in North America and the United Kingdom bakery business, which specializes in bagels, croissants, and specialty breads. In November 2013, the Company clearanced and closed the sale of Olivieri Foods, to Ebro Foods SA. Advisors' Opinion:- [By Gerrit De Vynck]
The Toronto-based food producer, which owns 90 percent of Canada Bread Co. (CBY), said in October it would explore options for the stake, including a possible sale as it divests assets to focus on its meat business. With several suitors evaluating the company, a sale is looking more likely, said one of the people, who asked not to be named because the talks are private. Maple Leaf hired Centerview Partners LLC and Royal Bank of Canada to look for buyers, the people said.
Top 10 Gas Utility Companies To Own For 2014: Diamond Offshore Drilling Inc. (DO)
Diamond Offshore Drilling, Inc. operates as an offshore oil and gas drilling contractor worldwide. It provides offshore drilling services in both the floater market, such as ultra-deepwater, deepwater, and mid-water; and in the non-floater and jack-up markets. The company operates a fleet of 44 offshore drilling rigs, consisting of 32 semisubmersibles, 7 jack-ups, and 5 dynamically positioned drillships, of which 4 are under construction. It serves independent oil and gas companies, and government-owned oil companies. The company was founded in 1989 and is headquartered in Houston, Texas. Diamond Offshore Drilling, Inc. is a subsidiary of Loews Corporation.
Advisors' Opinion:- [By Ben Levisohn]
The overwhelming majority of Loews can be valued as the sum of its three largest subsidiary businesses that also have publicly trading stock: CNA Financial (CNA), Diamond Offshore (DO) and Boardwalk Pipeline�(BWP). The sum of these stakes is equivalent to 97.7% of the market capitalization of Loews. For almost ��ree,��imknvestors also get ownership of Boardwalk�� B shares and general partnership, a small national hotel chain, natural gas and oil E&P HighMount and the $4B in fungible assets on Loews�� corporate balance sheet…
- [By John Divine]
The S&P 500 Index (SNPINDEX: ^GSPC ) finished higher for a sixth time in the last seven days, reaching yet another all-time closing record on Monday. Six out of 10 sectors finished higher as manufacturing data in the U.S. and China reassured investors that the global economic recovery isn't in danger of ending anytime soon. Shareholders invested in Lorillard, (NYSE: LO ) , Diamond Offshore Drilling (NYSE: DO ) , and Transocean Ltd. (NYSE: RIG ) didn't get the memo, however, as each stock ended near the bottom of the S&P today.
- [By Ben Levisohn]
Consider the losses: Noble Corp (NE) has plunged 19% so far this year,�while Transocean (RIG) has plummeted 16%, Rowan (RDC) has slid 15%, Ensco (ESV) has dropped 13% and Diamond Offshore Drilling (DO) has fallen 12%.
Top 10 Gas Utility Companies To Own For 2014: Family Dollar Stores Inc.(FDO)
Family Dollar Stores, Inc. operates a chain of self-service retail discount stores primarily for low and middle income consumers in the United States. The company offers consumables, including household chemicals, paper products, candy and snack products, health and beauty aids, hardware and automotive supplies, and pet food products and supplies; and home products, which comprise domestics, housewares, giftware products, and home decor products. It also provides apparel products and accessories consisting of men?s and women?s clothing products, boys? and girls? clothing products, infants? clothing products, shoes, and fashion accessories; and seasonal products and electronics, such as toys, stationery and school supplies, seasonal goods, and personal electronics. As of August 11, 2011, the company operated approximately 7,000 stores in rural and urban settings across 44 states. Family Dollar Stores, Inc. was founded in 1959 and is headquartered in Matthews, North Carolina .
Advisors' Opinion:- [By WWW.DAILYFINANCE.COM]
#fivemin-widget-blogsmith-image-305703{display:none}.cke_show_borders #fivemin-widget-blogsmith-image-305703,#postcontentcontainer #fivemin-widget-blogsmith-image-305703{width:570px;height:411px;display:block} NEW YORK -- The fight for penny pinchers is intensifying. Dollar Tree (DLTR) said Monday it is buying rival discounter Family Dollar (FDO) for $8.5 billion, significantly broadening its reach as it looks to fend off Walmart, which has been stepping up its courtship of lower-income customers The deal makes Dollar Tree the biggest player in the dollar store segment, with its more than 13,000 combined locations eclipsing current leader Dollar General (DG), which has about 11,300. Dollar stores grew during the recession as people across income groups searched for cheaper options. To attract a broader array of customers, they also expanded their offerings to include more groceries and brand-name products, instead of just the party favors and other knickknacks people often associated with them. More recently, however, sales at dollar stores have been suffering because the lower-income customers who go to them are facing persistent job instability and slow wage growth in the aftermath of the recession. Walmart Stores (WMT) and Kroger (KR) also have been opening smaller store formats to directly compete with dollar stores. During its current fiscal year, Walmart plans to open 270 to 300 smaller outlets designed to cater to shoppers looking for more convenience. Brian Sozzi, CEO and chief equities strategist at Belus Capital Advisors, said because the Dollar Tree deal will allow the company to lower expenses by merging its operations, it will ultimately be able to lower prices to better compete with Walmart. "Now they're going to take the fight back to Walmart," Sozzi said. The deal also gives Dollar Tree more flexibility. Dollar Tree is true to its name, with everything in its stores costing just a buck. The fixed pricing has helped attract more customer
- [By Nickey Friedman]
Opportunity is still vast
Dollar Tree believes the market can hold another 60% increase in its stores while simultaneously growing sales in each store more. It is finding ongoing sustainable success by adding perishable food, especially refrigerated and frozen goods, which Family Dollar Stores (NYSE: FDO ) and Dollar General (NYSE: DG ) have also seen success with. - [By Dan Moskowitz]
The shiniest dollar
Many investors and analysts like to debate which dollar store offers the best investment opportunity. The truth is that Dollar General, Dollar Tree Stores (NASDAQ: DLTR ) , and Family Dollar Stores (NYSE: FDO ) are all likely to be quality long-term investments.
Top 10 Gas Utility Companies To Own For 2014: Ambit Biosciences Corp (AMBI)
Ambit Biosciences Corporation, incorporated on May 17, 2000, is a biopharmaceutical company. The Company focused on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology, autoimmune and inflammatory diseases by inhibiting kinases that are important drivers for those diseases. The Company�� lead drug candidate, quizartinib, is in Phase IIb clinical development in patients with relapsed/refractory acute myeloid leukemia (AML). The Company�� second drug candidate in clinical development, AC410, is a potent, selective, orally-administered, small molecule inhibitor of Janus kinase 2 (JAK2) that has potential utility for the treatment of autoimmune and inflammatory diseases. The Company�� third program consists of two selective small molecule compounds, AC708 and AC855, which inhibit the colony-stimulating factor-1 receptor (CSF1R), a receptor tyrosine kinase.
Quizartinib
The Company�� lead drug candidate, quizartinib, is a once-daily, orally-administered, potent and selective inhibitor of FLT3, a validated target in the treatment of AML, and is in Phase IIb clinical development. The FLT3-ITD mutation acts like a power switch that causes leukemic cells, or blasts, to spread more aggressively and grow back more rapidly following chemotherapy, conferring an especially poor survival outcome. Quizartinib is designed to turn off this switch. The Company is developing a companion diagnostic test with Genoptix Medical Laboratory, a Novartis company, to identify FLT3-ITD positive patients.
AC410
The Company�� advanced drug candidate, AC410, is a potent, selective, orally-administered, small molecule inhibitor of JAK2, which has potential utility for the treatment of autoimmune and inflammatory diseases. Signaling through JAK controls the activation, proliferation and survival of various types of immune cells, and overactivation of such cells can exacerbate a range of normal inflammatory processes, resulting i! n inflammation. The Company�� initial JAK2 drug candidate, AC430, is a racemic mixture (50/50) of two enantiomers (mirror images), AC410 and AC409, and was studied in a Phase I clinical trial.
CSF1R Program
The Company is developing two potent and exquisitely selective small molecule compounds, AC708 and AC855 that both inhibit CSF1R and have potential utility in oncology, autoimmune and inflammatory diseases. Signaling through CSF1R controls the activation, proliferation and survival of macrophages, which are key mediators of immune system function and over-activation of macrophages, may result in exacerbation of certain diseases.
The Company competes with Abbvie Inc., Akinion Pharmaceuticals AB, Amgen Inc., ARIAD Pharmaceuticals, Inc., AROG Pharmaceuticals, LLC, ArQule, Inc., Astellas, AstraZeneca plc, Bayer AG, Celgene Corporation, Daiichi-Sankyo Company Limited, Galapagos NV, GlaxoSmithKline plc, Incyte Corporation, Janssen Pharmaceuticals, Inc., Johnson & Johnson, Eli Lilly and Company, Novartis, Onyx Pharmaceuticals, Inc., Pfizer, Rigel Pharmaceuticals, Inc., F. Hoffman-LaRoche Ltd, and Vertex Pharmaceuticals Incorporated.
Advisors' Opinion:- [By Wallace Witkowski]
Ambit Biosciences Corp. (AMBI) �shares fell more than 37% to $8 in moderate volume. The small-cap biotech said it will not file an accelerated approval application with the Food and Drug Administration for its leukemia drug quizartinib after the agency disagreed with the company about the use of certain study data to support the drug�� efficacy.
Top 10 Gas Utility Companies To Own For 2014: Raytheon Company(RTN)
Raytheon Company, together with its subsidiaries, provides electronics, mission systems integration, and other capabilities in the areas of sensing, effects, and command, control, communications, and intelligence systems, as well as mission support services in the United States and internationally. It operates in six segments: Integrated Defense Systems, Intelligence and Information Systems, Missile Systems, Network Centric Systems, Space and Airborne Systems, and Technical Services. The Integrated Defense Systems segment provides integrated naval, air, and missile defense and civil security response solutions. The Intelligence and Information Systems segment offers intelligence, surveillance and reconnaissance, advanced cyber solutions, weather and environmental solutions, and information-based solutions for law enforcement and homeland security. The Missile Systems segment develops and produces weapon systems, including missiles, smart munitions, close-in weapon systems, projectiles, kinetic kill vehicles, and directed energy effectors for the armed forces of the U.S. and other allied nations. The Network Centric Systems segment provides net-centric mission solutions, including integrated communications systems, command and control systems, combat systems, and operations and precision components for the U.S. federal, state, and local government customers, as well as civil customers. The Space and Airborne Systems segment designs and develops integrated systems and solutions for missions, including intelligence, surveillance, and reconnaissance; precision engagement; unmanned aerial operations; and space. The Technical Services segment provides training, logistics, engineering, product support, and operational support services for the mission support, homeland security, space, civil aviation, counterproliferation, and counterterrorism markets. Raytheon Company was founded in 1922 and is based in Waltham, Massachusetts.
Advisors' Opinion:- [By Chuck Saletta]
Raytheon (NYSE: RTN ) is a selection for the real-money Inflation-Protected Income Growth portfolio. Like any investment, it needs to be reviewed from time to time to see if it's still worth owning. In the brief video below, portfolio manager Chuck Saletta reviews its valuation, balance sheet, and dividends, and decides whether to hold on to the stock or let it go.
Top 10 Gas Utility Companies To Own For 2014: Petroleo Brasileiro S.A.- Petrobras(PBR)
Petroleo Brasileiro S.A. primarily engages in oil and natural gas exploration and production, refining, trade, and transportation businesses. The company?s Exploration and Production segment involves in the exploration, production, development, and production of oil, liquefied natural gas (LNG), and natural gas in Brazil. This segment supplies its products to the refineries in Brazil, as well as sells surplus petroleum and byproducts in domestic and foreign markets. Its Supply segment engages in the refining, logistics, transportation, and trade of oil and oil products; export of ethanol; and extraction and processing of schist, as well as holds interests in companies of the petrochemical sector in Brazil. The Gas and Energy segment involves in the transportation and trade of natural gas produced in or imported into Brazil; transportation and trade of LNG; and generation and trade of electric power. In addition, the segment has interests in natural gas transportation and d istribution companies; and thermoelectric power stations in Brazil, as well engages in fertilizer business. The Distribution segment distributes oil products, ethanol, and compressed natural gas in Brazil. The International segment involves in the exploration and production of oil and gas, as well as in supplying, gas and energy, and distribution operations in the Americas, Africa, Europe, and Asia. Further, the company involves in biofuel production business. Petroleo Brasileiro was founded in 1953 and is based in Rio de Janeiro, Brazil.
Advisors' Opinion:- [By Jonas Elmerraji]
Nearest Resistance: $13��br>Nearest Support: $10��br>Catalyst: Brazil Elections
Shares of Brazilian national oil company Petrobras (PBR) are getting sold off on big volume this afternoon, down more than 14% following the results of the Brazilian election. President Dilma Rousseff's re-election in Brazil means that the restrictions her administration has placed on PBR are here to stay. Shares had already spent the last month selling off thanks to poll projections, but today's drop is particularly nasty -- the worst one-day decline in PBR in six years.
- [By WALLSTCHEATSHEET]
Petrobras participates in an area that is essential to many consumers, businesses, and overall global growth. The stock has been in a range this past quarter, but is currently trading at highs slightly below its all time highs. During the last four quarters, the stock has seen decreasing earnings and revenue figures, leaving investors with mixed feelings. Relative to its peers and sector, Petrobras has trailed in performance by a significant margin. STAY AWAY from Petrobras for now.
No comments:
Post a Comment